Physician profile
Brenda Sorensen Coen
NPI 1104918739
$3,669.35
in general payments reported to CMS, 2019-2025
12 companies · $501 in 2025
The $501 reported for 2025 was more than what 83% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $553 · 2021: $651 · 2022: $538 · 2023: $329 · 2024: $163 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,035.89 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $899.77 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $505.71 | 2023-2025 | Infuse, Alden Scleral Zenlens |
| Alcon Vision LLC | $289.75 | 2019-2025 | Precision7 |
| Sight Sciences, INC. | $252.70 | 2022 | |
| Coopervision INC. | $165.07 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Novartis Pharmaceuticals Corporation | $124.16 | 2021 | |
| Shire North American Group INC | $124.07 | 2019 | |
| Rxsight INC | $113.93 | 2024 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Dompe US, INC. | $105.57 | 2021 | |
| Sun Pharmaceutical Industries INC. | $33.33 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Coen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.